iCura given CRO status by Akoya Biosciences

2022 04 18 13 42 3384 Dna Genome Gene Targeted 400

iCura Diagnostics was named a fully qualified contract research organization (CRO) by Akoya Biosciences.

iCura provides diagnostic testing and services for the pharmaceutical industry, academic research centers, and partner CROs and laboratories. The company has recently focused its services on multiplexing immunofluorescence (IF)/immunohistochemistry (IHC), circulating tumor cells, and genomic services.

Page 1 of 35
Next Page